DC
CRMD icon

Diametric Capital’s CorMedix CRMD Stock Holding History

Diametric Capital’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-124,987
Closed -$1.45M – 505
2025
Q4 		$1.45M Buy
124,987
+70,079
+128% +$775K 0.39% 58
2025
Q3 		$639K Buy
+54,908
New +$664K 0.24% 106
2025
Q2 		– Sell
-37,854
Closed -$233K – 333
2025
Q1 		$233K Buy
+37,854
New +$392K 0.28% 124

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Diametric Capital's CRMD Position: Q1 2026 in Review

Diametric Capital sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 124,987 shares — an estimated $1.45M sold.

Diametric Capital first reported a position in CRMD in Q1 2025 and held it in 3 quarters. The position peaked at $1.45M in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Diametric Capital reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • Diametric Capital sold 124,987 CorMedix shares in Q1 2026, an estimated $1.45M.
  • Diametric Capital first reported a position in CorMedix in Q1 2025 and held it in 3 quarters.
  • Diametric Capital's CorMedix position peaked at $1.45M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.